Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
NV18-05-00340
Agentura Pro Zdravotnický Výzkum České Republiky
PubMed
33171728
PubMed Central
PMC7694967
DOI
10.3390/antibiotics9110785
PII: antibiotics9110785
Knihovny.cz E-zdroje
- Klíčová slova
- GIT, VRE, clonality, hemato-oncological patients,
- Publikační typ
- časopisecké články MeSH
Enterococci are important bacterial pathogens, and their significance is even greater in the case of vancomycin-resistant enterococci (VRE). The study analyzed the presence of VRE in the gastrointestinal tract (GIT) of hemato-oncological patients. Active screening using selective agars yielded VRE for phenotypic and genotypic analyses. Isolated strains were identified with MALDI-TOF MS, (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) their susceptibility to antibiotics was tested, and resistance genes (vanA, vanB, vanC-1, vanC2-C3) and genes encoding virulence factors (asa1, gelE, cylA, esp, hyl) were detected. Pulsed-field gel electrophoresis was used to assess the relationship of the isolated strains. Over a period of three years, 103 VanA-type VRE were identified in 1405 hemato-oncological patients. The most frequently detected virulence factor was extracellular surface protein (84%), followed by hyaluronidase (40%). Unique restriction profiles were observed in 33% of strains; clonality was detected in 67% of isolates. The study found that 7% of hemato-oncological patients carried VRE in their GIT. In all cases, the species identified was Enterococcus faecium. No clone persisted for the entire 3-year study period. However, genetically different clusters were observed for shorter periods of time, no longer than eight months, with identical VRE spreading among patients.
Zobrazit více v PubMed
Kolář M. Vancomycin-resistant enterococci. Klin. Mikrobiol. Infekc. Lek. 2018;24:50–56. PubMed
Sievert D.M., Ricks P., Edwards J.R., Schneider A., Patel J., Srinivasan A., Kallen A., Limbago B., Fridkin S., National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect. Control Hosp. Epidemiol. 2013;34:1–14. doi: 10.1086/668770. PubMed DOI
Michael K.E., No D., Roberts M.C. VanA-positive multi-drug-resistant Enterococcus spp. isolated from surfaces of a US hospital laundry facility. J. Hosp. Infect. 2017;95:218–223. doi: 10.1016/j.jhin.2016.10.017. PubMed DOI
Kolář M., Heinigeová B., Bartoníková N., Čermák P., Burgetová D., Dorníková G., Dovalová M., Frýbortová V., Horová E., Chmelařová E., et al. Gram-positive pathogens in bloodstream infections—A multicenter study. Klin. Mikrobiol. Inf. Lek. 2003;9:244–252.
Herkel T., Uvizl R., Doubravska L., Adamus M., Gabrhelik T., Htoutou Sedlakova M., Kolar M., Hanulik V., Pudova V., Langova K., et al. Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2016;160:448–455. doi: 10.5507/bp.2016.014. PubMed DOI
Pudová V., Htoutou Sedláková M., Kolář M., Working Group Clonality of bacterial pathogens causing hospital-acquired pneumonia. Curr. Microbiol. 2016;73:312–316. doi: 10.1007/s00284-016-1058-0. PubMed DOI
Arias C.A., Murray B.E. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 2012;10:266–278. doi: 10.1038/nrmicro2761. PubMed DOI PMC
Arthur M., Reynolds P.E., Depardieu F., Evers S., Dutka-Malen S., Quintiliani R., Jr., Courvalin P. Mechanisms of glycopeptide resistance in enterococci. J. Infect. 1996;32:11–16. doi: 10.1016/S0163-4453(96)80003-X. PubMed DOI
Murray B.E. Vancomycin-resistant enterococci. Am. J. Med. 1997;102:284–293. doi: 10.1016/S0002-9343(99)80270-8. PubMed DOI
Reynolds P.E., Courvalin P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob. Agents Chemother. 2005;49:21–25. doi: 10.1128/AAC.49.1.21-25.2005. PubMed DOI PMC
Courvalin P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 2006;42(Suppl. S1):S25–S34. doi: 10.1086/491711. PubMed DOI
Uttley A.H., Collins C.H., Naidoo J., George R.C. Vancomycin-resistant enterococci. Lancet. 1988;1:57–58. doi: 10.1016/S0140-6736(88)91037-9. PubMed DOI
Kolář M., Vágnerová I., Kohnová I. Detection of vancomycin-resistant enterococci in Teaching Hospital, Olomouc. Klin. Mikrobiol. Inf. Lek. 1997;3:189–191.
Kolar M., Htoutou Sedlakova M., Pudova V., Roderova M., Novosad J., Senkyrikova M., Szotkowska R., Indrak K. Incidence of fecal Enterobacteriaceae producing broad-spectrum beta-lactamases in patients with hematological malignancies. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2015;159:100–103. doi: 10.5507/bp.2014.042. PubMed DOI
Heath C.H., Blackmore T.K., Gordon D.L. Emerging resistance in Enterococcus spp. Med. J. Aust. 1996;164:116–120. doi: 10.5694/j.1326-5377.1996.tb101370.x. PubMed DOI
Weber D.J., Rutala W.A. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 1997;18:306–309. doi: 10.2307/30141222. PubMed DOI
Jordens J.Z., Bates J., Griffiths D.T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 1994;34:515–528. doi: 10.1093/jac/34.4.515. PubMed DOI
Heisel R.W., Sutton R.R., Mascara G.P., Winger D.G., Weber D.R., Lim S.H., Oleksiuk L.M. Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine. Leuk. Lymphoma. 2017;58:2565–2572. doi: 10.1080/10428194.2017.1306645. PubMed DOI
Kolar M., Pantucek R., Vagnerova I., Kesselova M., Sauer P., Matouskova I., Doskar J., Koukalova D., Hejnar P. Genotypic characterisation of vancomycin-resistant Enterococcus faecium isolates from haemato-oncological patients at Olomouc University Hospital, Czech Republic. Clin. Microbiol. Infect. 2006;12:353–360. doi: 10.1111/j.1469-0691.2006.01365.x. PubMed DOI
Paterson D.L., Muto C.A., Ndirangu M., Linden P.K., Potoski B.A., Capitano B., Bonomo R.A., Aron D.C., Donskey C.J. Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens. Antimicrob. Agents Chemother. 2008;52:465–469. doi: 10.1128/AAC.01316-06. PubMed DOI PMC
European Antimicrobial Resistance Surveillance Network (EARS-Net) [(accessed on 6 August 2019)]; Available online: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/ears-net.
European Centre for Disease Prevention and Control (ECDC) Antimicrobial Resistance Surveillance in Europe 2015. [(accessed on 6 August 2019)]; Available online: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2015.
European Centre for Disease Prevention and Control Antimicrobial Resistance Surveillance in Europe 2016. [(accessed on 6 August 2019)]; Available online: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2016.
European Centre for Disease Prevention and Control Antimicrobial Resistance Surveillance in Europe 2017. [(accessed on 6 August 2019)]; Available online: https://ecdc.europa.eu/sites/portal/files/documents/EARS-Net-report-2017-update-jan-2019.pdf.
Kolar M., Pantucek R., Vagnerova I., Sauer P., Kesselova M., Cekanova L., Koukalova D., Doskar J., Ruzickova V. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol. 2006;29:121–125. PubMed
AbdelKhalek A., Abutaleb N.S., Mohammad H., Seleem M.N. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE) PLoS ONE. 2018;13:e0199710. doi: 10.1371/journal.pone.0199710. PubMed DOI PMC
Yang J.X., Li T., Ning Y.Z., Shao D.H., Liu J., Wang S.Q., Liang G.W. Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. Infect. Genet. Evol. 2015;33:253–260. doi: 10.1016/j.meegid.2015.05.012. PubMed DOI
Alevizakos M., Gaitanidis A., Nasioudis D., Tori K., Flokas M.E., Mylonakis E. Colonization with vancomycin-resistant enterococci and risk for bloodstream infection among patients with malignancy: A systematic review and meta-analysis. Open Forum Infect. Dis. 2016;4:ofw246. doi: 10.1093/ofid/ofw246. PubMed DOI PMC
Ballo O., Tarazzit I., Stratmann J., Reinheimer C., Hogardt M., Wichelhaus T.A., Kempf V., Serve H., Finkelmeier F., Brandts C. Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy. PLoS ONE. 2019;14:e0210991. doi: 10.1371/journal.pone.0210991. PubMed DOI PMC
Weber S., Hogardt M., Reinheimer C., Wichelhaus T.A., Kempf V., Kessel J., Wolf S., Serve H., Steffen B., Scheich S. Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases. Ann. Hematol. 2019;98:763–773. doi: 10.1007/s00277-019-03607-z. PubMed DOI
Mantey J., Min L., Cassone M., Gibson K.E., Mody L. Changing dynamics of colonization in nursing facility patients over time: Reduction in methicillin-resistant Staphylococcus aureus (MRSA) offset by increase in vancomycin-resistant Enterococcus (VRE) prevalence. Infect. Control Hosp. Epidemiol. 2019;40:1069–1070. doi: 10.1017/ice.2019.169. PubMed DOI PMC
Talaga K., Odrowąż-Konduracka D., Paradowska B., Jagiencarz-Starzec B., Wolak Z., Bulanda M., Szcypta A. Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland. Adv. Clin. Exp. Med. 2018;27:111–117. doi: 10.17219/acem/68265. PubMed DOI
Jovanović M., Tošić T., Jovanović S., Stošović R., Stevanović G., Velebit B., Zervos M.J. Presence of the esp gene in Enterococcus faecium derived from oropharyngeal microbiota of haematology patients. Arch. Oral Biol. 2018;88:54–59. doi: 10.1016/j.archoralbio.2018.01.008. PubMed DOI
Vu J., Carvalho J. Enterococcus: Review of its physiology, pathogenesis, diseases and the challenges it poses for clinical microbiology. Front. Biol. 2011;6:357–366. doi: 10.1007/s11515-011-1167-x. DOI
Farahani A. State of globe: Enterococci: Virulence factors and biofilm formation. J. Glob. Infect. Dis. 2016;8:1–2. doi: 10.4103/0974-777X.176139. PubMed DOI PMC
Marchi A.P., Perdigão Neto L.V., Martins R.C.R., Rizek C.F., Camargo C.H., Moreno L.Z., Moreno A.M., Batista M.V., Basqueira M.S., Rossi F., et al. Vancomycin-resistant enterococci isolates colonizing and infecting haematology patients: Clonality, and virulence and resistance profile. J. Hosp. Infect. 2018;99:346–355. doi: 10.1016/j.jhin.2017.10.010. PubMed DOI
Ochoa S.A., Escalona G., Cruz-Córdova A., Dávila L.B., Saldaña Z., Cázares-Domímguez V., Eslava C.A., López-Martínez B., Hernández-Castro R., Aquino-Jarquin G., et al. Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City. BMC Microbiol. 2013;13:291. doi: 10.1186/1471-2180-13-291. PubMed DOI PMC
Ryan L., O’Mahony E., Wrenn C., FitzGerald S., Fox U., Boyle B., Schaffer K., Werner G., Klare I. Epidemiology and molecular typing of VRE bloodstream isolates in an Irish tertiary care hospital. J. Antimicrob. Chemother. 2015;70:2718–2724. doi: 10.1093/jac/dkv185. PubMed DOI
Gozalan A., Coskun-Ari F.F., Ozdem B., Unaldi O., Celikbilek N., Kirca F., Aydogan S., Muderris T., Guven T., Acikgoz Z.C., et al. Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Turkey. J. Med. Microbiol. 2015;64:759–766. doi: 10.1099/jmm.0.000088. PubMed DOI
Bressan R., Knezevich A., Monticelli J., Campanile F., Busetti M., Santagati M., Dolzani L., Milan A., Bongiorno D., Di Santolo M., et al. Spread of vancomycin-resistant Enterococcus faecium isolates despite validated infection control measures in an Italian hospital: Antibiotic resistance and genotypic characterization of the endemic strain. Microb. Drug Resist. 2018;24:1148–1155. doi: 10.1089/mdr.2017.0314. PubMed DOI
Noble M.A., Isaac-Renton J.L., Bryce E.A., Roscoe D.L., Roberts F.J., Walker M., Scharf S., Walsh A., Altamirano-Dimas M., Gribble M. The toilet as a transmission vector of vancomycin-resistant enterococci. J. Hosp. Infect. 1998;40:237–241. doi: 10.1016/S0195-6701(98)90141-4. PubMed DOI
The European Committee on Antimicrobial Susceptibility Testing—EUCAST 2018. [(accessed on 6 August 2019)]; Available online: http://www.eucast.org/
Dutka-Malen S., Evers S., Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR [published correction appears in J Clin Microbiol. 1995 May;33:1434] J. Clin. Microbiol. 1995;33:24–27. doi: 10.1128/JCM.33.1.24-27.1995. PubMed DOI PMC
Vankerckhoven V., Van Autgaerden T., Vael C., Lammens C., Chapelle S., Rossi R., Jabes D., Goossens H. Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J. Clin. Microbiol. 2004;42:4473–4479. doi: 10.1128/JCM.42.10.4473-4479.2004. PubMed DOI PMC
Pantůček R., Götz F., Doskar J., Rosypal S. Genomic variability of Staphylococcus aureus and the other coagulase-positive Staphylococcus species estimated by macrorestriction analysis using pulsed-field gel electrophoresis. Int. J. Syst. Bacteriol. 1996;46:216–222. doi: 10.1099/00207713-46-1-216. PubMed DOI
Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J. Clin. Microbiol. 1995;33:2233–2239. doi: 10.1128/JCM.33.9.2233-2239.1995. PubMed DOI PMC
Bacterial Infections, Antimicrobial Resistance and Antibiotic Therapy
Implementation of Antibiotic Stewardship in a University Hospital Setting